Canopy Growth is a world-leading diversified cannabis and cannabinoid-based consumer product company. HudsonWest advised Canopy Growth across multiple equity-linked transactions spanning 2022 and 2023, helping the company manage a complex convertible maturity through a combination of equitizations and a bespoke refinancing.
With the notes approaching current status and Canopy’s stock having fallen well below the conversion price, HudsonWest designed an equitization of ~44% of the outstanding notes at a discount to par with a floor price — saving over C$11MM in annual interest expense and moving Canopy from a net debt to a net cash position.
With the balance of the C$237MM maturity approaching, HudsonWest helped execute a two-part solution: a C$12.5MM equitization in June 2023, followed by a C$193MM refinancing composed of cash, common shares and a new zero-coupon convertible note. Despite significant regulatory, legal and contractual constraints, Canopy retained C$92MM in cash it otherwise would have owed at maturity.
Canopy Growth engaged HudsonWest in 2022 as it faced a challenging set of circumstances: a C$600MM convertible maturity approaching, a stock price well below the original conversion price and meaningful regulatory and structural constraints on available options.
In June 2022, HudsonWest designed an innovative equitization of ~44% of the outstanding notes at a discount to par, with a floor price to protect against stock price volatility. The transaction saved over C$11MM in annual interest expense and meaningfully strengthened Canopy’s balance sheet.
A year later, with the full maturity approaching, HudsonWest returned with a two-part solution that allowed Canopy to retain C$92MM in cash it would otherwise have owed — navigating a complex web of regulatory, legal and contractual constraints to achieve a constructive outcome.
HudsonWest brings the same independence and expertise to every engagement.